
Anixa Biosciences ANIX
$ 3.18
0.63%
Quarterly report 2025-Q2
added 09-10-2025
Anixa Biosciences Total Inventories 2011-2026 | ANIX
Quarterly Total Inventories Anixa Biosciences
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 33.4 K | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 33.4 K | 33.4 K | 33.4 K |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | ||
|
Burning Rock Biotech Limited
BNR
|
123 M | $ 22.01 | 11.81 % | $ 237 M | ||
|
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
1.66 M | $ 5.72 | 2.88 % | $ 168 M | ||
|
BioNano Genomics
BNGO
|
13.3 M | $ 1.62 | 1.89 % | $ 2.06 M | ||
|
DarioHealth Corp.
DRIO
|
5.06 M | $ 12.64 | 20.15 % | $ 359 M | ||
|
DexCom
DXCM
|
560 M | $ 67.67 | 1.7 % | $ 26.1 B | ||
|
Castle Biosciences
CSTL
|
8.14 M | $ 38.51 | -0.08 % | $ 1.07 B | ||
|
Exact Sciences Corporation
EXAS
|
162 M | $ 101.53 | -0.21 % | $ 18.8 B | ||
|
Danaher Corporation
DHR
|
2.33 B | $ 234.56 | 1.82 % | $ 171 B | ||
|
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | ||
|
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | ||
|
CareDx, Inc
CDNA
|
19.5 M | $ 20.02 | 4.6 % | $ 1.08 B | ||
|
Guardant Health
GH
|
71.1 M | $ 102.55 | 0.79 % | $ 12.6 B | ||
|
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | ||
|
Aspira Women's Health
AWH
|
316 K | - | -6.19 % | $ 10.5 M | ||
|
Illumina
ILMN
|
547 M | $ 140.15 | 4.32 % | $ 22.3 B | ||
|
Charles River Laboratories International
CRL
|
279 M | $ 208.19 | 2.86 % | $ 10.7 B | ||
|
Myriad Genetics
MYGN
|
27.5 M | $ 6.19 | 0.73 % | $ 561 M | ||
|
NeoGenomics
NEO
|
26.7 M | $ 12.18 | 3.53 % | $ 1.54 B | ||
|
Neogen Corporation
NEOG
|
191 M | $ 7.3 | 4.21 % | $ 1.58 B | ||
|
Natera
NTRA
|
35.4 M | $ 235.89 | 3.08 % | $ 23.2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
188 M | $ 173.85 | 0.13 % | $ 19.3 B | ||
|
OPKO Health
OPK
|
56.8 M | $ 1.26 | -0.39 % | $ 874 M | ||
|
Laboratory Corporation of America Holdings
LH
|
493 M | $ 253.05 | 0.55 % | $ 21.2 B | ||
|
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
2.3 M | $ 197.18 | 4.51 % | $ 16.3 B | ||
|
IDEXX Laboratories
IDXX
|
382 M | $ 682.72 | 1.9 % | $ 56.3 B | ||
|
Lantheus Holdings
LNTH
|
68 M | $ 69.25 | 2.94 % | $ 4.79 B | ||
|
Pacific Biosciences of California
PACB
|
56.7 M | $ 1.96 | 6.52 % | $ 497 M | ||
|
Agilent Technologies
A
|
830 M | $ 142.17 | 3.08 % | $ 43.2 B | ||
|
Mettler-Toledo International
MTD
|
342 M | $ 1 439.83 | 2.01 % | $ 30.6 B | ||
|
Organovo Holdings
ONVO
|
297 K | - | -2.3 % | $ 19.4 M | ||
|
Biomerica
BMRA
|
1.49 M | $ 2.56 | 1.19 % | $ 5.88 M |